What is Regenxbio's current ratio?

Regenxbio (RGNX) reported current ratio of 2.6× in Q1 2026.

How has Regenxbio's current ratio changed year-over-year?

Regenxbio's current ratio decreased by 10.6% year-over-year, from 2.9× to 2.6×.

What is the long-term trend for Regenxbio's current ratio?

Over 5 years (2020 to 2025), Regenxbio's current ratio has grown at a -18.2% compound annual growth rate (CAGR), from 6.5× to 2.4×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Regenxbio RGNX Current ratio

Current ratio at other companies

Regeneron PharmaceuticalsREGN

3.6×-1.4×

Sarepta Therapeutics, Inc.SRPT

4.6×+0.6×

BiogenBIIB

3.1×+1.6×

BioMarin PharmaceuticalsBMRN

5.8×+0.3×

EyePoint, Inc. EYPT

6.7×-1.2×

Ultragenyx PharmaceuticalRARE

2×-0.4×

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Where this comes from

Calculated from Regenxbio’s reported figures.

total current assets/total current liabilities=2.6×

Based on the most recent quarter.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's current ratio?: Regenxbio (RGNX) reported current ratio of 2.6× in Q1 2026.
How has Regenxbio's current ratio changed year-over-year?: Regenxbio's current ratio decreased by 10.6% year-over-year, from 2.9× to 2.6×.
What is the long-term trend for Regenxbio's current ratio?: Over 5 years (2020 to 2025), Regenxbio's current ratio has grown at a -18.2% compound annual growth rate (CAGR), from 6.5× to 2.4×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.